| product_name | (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid |
| CAS_number | Unavailable |
| formula | C20H20N2O2 |
| molar_mass | 320.39 |
| color | Unavailable |
| phase | Unavailable |
| density | Unavailable |
| melting_point | Unavailable |
| boiling_point | Unavailable |
| solubility | Unavailable |
| vapor_pressure | Unavailable |
| pKa | Unavailable |
| logP | Unavailable |
| stability | Unavailable |
| hazard_classification | Unavailable |
What is the primary function of (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid?
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid is a compound utilized in pharmaceutical research due to its potential therapeutic applications. It is commonly studied for its interactions with specific biological targets and its effects on cellular processes.
How is (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid synthesized?
The synthesis of (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid involves several steps, including the combination of precursor molecules under specific reaction conditions. Detailed protocols for its preparation are available in scientific literature and research publications.
What are the potential applications of (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid in medicine?
Researchers are investigating the use of (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid in the development of novel drugs for various conditions, such as cancer, neurological disorders, and inflammatory diseases. Its molecular structure allows for targeted interactions with specific biological pathways.
How does (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid exert its pharmacological effects?
The pharmacological effects of (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid are primarily mediated by its ability to modulate key signaling pathways in cells. By binding to specific targets, this compound can influence cellular responses and biochemical processes, leading to therapeutic outcomes.
What research studies have been conducted on the use of (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid?
Numerous research studies have explored the potential of (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid in preclinical and clinical settings. These investigations have focused on its efficacy, safety, and mechanisms of action, providing valuable insights for drug development.
Are there any side effects associated with the use of (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid?
As with any pharmaceutical compound, the use of (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid may be associated with potential side effects. These can vary depending on the dose, administration route, and individual patient factors. Clinical studies are ongoing to evaluate its safety profile.
What is the current status of clinical trials involving (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid?
Several clinical trials are investigating the use of (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid in patients with various medical conditions. These trials aim to assess its efficacy, safety, and potential benefits for treating specific diseases. Results from these studies will inform future therapeutic applications.
What are the prospects for the future development of (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid as a pharmaceutical agent?
The promising preclinical and clinical data surrounding (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid suggest that it holds significant potential as a novel therapeutic agent. Further research and development efforts will likely focus on optimizing its pharmacological properties and exploring new applications in medicine.